Oral antiplatelet therapy in secondary prevention of cardiovascular events: an assessment from the payer's perspective.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2007 AND VI 25 AND IP 12
Results: 7
1
2
Economic evidence at the local level : options for making it more useful.
- Published in:
- 2007
- By:
- Publication type:
- journal article
3
Atorvastatin: a pharmacoeconomic review of its use in the primary and secondary prevention of cardiovascular events.
- Published in:
- 2007
- By:
- Publication type:
- journal article
4
NICE cost-effectiveness appraisal of cholinesterase inhibitors: was the right question posed? Were the best tools used?
- Published in:
- 2007
- By:
- Publication type:
- journal article
5
When NICE says no!
- Published in:
- 2007
- By:
- Publication type:
- commentary
6
ACKNOWLEDGEMENT.
- Published in:
- PharmacoEconomics, 2007, v. 25, n. 12, p. 991, doi. 10.2165/00019053-200725120-00001
- Publication type:
- Article
7
Recombinant factor VIIa (eptacog alfa): a pharmacoeconomic review of its use in haemophilia in patients with inhibitors to clotting factors VIII or IX.
- Published in:
- 2007
- By:
- Publication type:
- journal article